Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1950 studies found for:    (uterine OR endometrial) AND cancer
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Not yet recruiting Study of Avelumab in Patients With MSS, MSI-H and POLE-mutated Recurrent or Persistent Endometrial Cancer
Condition: Metastatic Endometrial Cancer
Intervention: Drug: Avelumab
2 Active, not recruiting Estrogen, Diet, Genetics and Endometrial Cancer
Conditions: Cancer;   Endometrial Cancer;   Ovarian Cancer;   Corpus Uteri;   Endometrium
Intervention: Behavioral: Questionnaire
3 Active, not recruiting Physical Activity After Endometrial Cancer
Condition: Endometrial Cancer
Interventions: Behavioral: Personalized Exercise Program;   Behavioral: Questionnaire;   Behavioral: Suggested Exercise Program
4 Recruiting Molecular Markers in Treatment in Endometrial Cancer
Conditions: Endometrial Neoplasms;   Neoplasm Metastasis
Intervention: Procedure: Tumor biopsy study
5 Completed Study of Insulin Resistance and Endometrial Cancer in Harris County, Texas
Condition: Endometrial Cancer
Intervention: Behavioral: Questionnaire
6 Active, not recruiting Telephone Follow-up After Treatment for Endometrial Cancer
Condition: Endometrial Cancer
Intervention: Other: Telephone Follow-up
7 Recruiting Irreversible Electroporation(IRE) For Uterine Cervical Neoplasms
Condition: Uterine Cervical Neoplasms
Interventions: Procedure: Irreversible electroporation (IRE);   Device: NanoKnife
8 Active, not recruiting Optimized Magnetic Resonance Brachytherapy (MR BT) in Cervix Cancer
Condition: Cervix Cancer
Intervention: Radiation: optimised magnetic resonance image-guided intra-uterine brachytherapy
9 Recruiting Enzalutamide in Combination With Carboplatin and Paclitaxel in Endometrial Cancer
Condition: Endometrial Cancer
Interventions: Drug: Enzalutamide;   Drug: Carboplatin;   Drug: Paclitaxel
10 Completed
Has Results
Carboplatin, Docetaxel, and Radiation Therapy in Treating Patients With Stage III/IV, or Recurrent Endometrial Cancer
Condition: Endometrial Cancer
Interventions: Drug: carboplatin;   Drug: docetaxel;   Radiation: radiation therapy
11 Unknown  Prophylactic Irradiation of the Para-Aortic Lymph Nodes and Supraclavicular Lymph Nodes in Locally Advanced Uterine Cervical Cancer
Condition: Cervical Cancer
Intervention: Radiation: Prophylactic Irradiation of the Para-Aortic Lymph Nodes and supraclavicular lymph nodes in Locally Advanced Uterine Cervical Cancer
12 Active, not recruiting Study of Post Operative Pain in Endometrial Cancer Robotic Versus Laparotomy
Condition: Endometrial Cancer
Intervention:
13 Recruiting Endometrial Cancer Testing With Vaginal and Endometrial Cell Samples
Conditions: Endometrial Cancer;   Gynecological Cancers
Intervention:
14 Completed Studies of the Tumour Suppressor Gene PTEN - Endometrial Cancer
Condition: Endometrial Neoplasms
Interventions: Behavioral: questionnaire;   Procedure: Blood sample-DNA testing / Tumour-genetic markers
15 Completed Diet and Physical Activity in Uterine Cancer Survivors
Condition: Endometrial Neoplasms
Intervention: Behavioral: Shape-Up following cancer treatment
16 Recruiting Lymph Node Mapping in Patients With Endometrial Cancer
Condition: Endometrial Cancer
Interventions: Procedure: sentinel lymph node detection;   Drug: indocyanine green solution;   Drug: isosulfan blue;   Procedure: sentinel lymph node biopsy
17 Unknown  Epidemiology of Uterine Cancer in Taiwan
Condition: Uterine Cancers
Intervention: Other: Histologic types
18 Unknown  Study of Genes and the Environment in Patients With Endometrial Cancer in the East Anglia, Oxford, Trent, or West Midlands Regions of the United Kingdom
Condition: Endometrial Cancer
Interventions: Genetic: polymorphism analysis;   Other: laboratory biomarker analysis;   Other: questionnaire administration
19 Active, not recruiting Risk Factors for Endometrial Cancer in Black Women
Condition: Endometrial Cancer
Interventions: Other: questionnaire administration;   Other: study of socioeconomic and demographic variables;   Procedure: evaluation of cancer risk factors
20 Terminated Clinical Trial of PM00104 (Zalypsis®) in Patients With Advanced and/or Metastatic Endometrial or Cervical Cancer Previously Treated With One Line of Systemic Chemotherapy
Conditions: Uterine Cervical Cancer;   Endometrial Cancer
Intervention: Drug: Zalypsis ( PM00104)

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.